https://www.selleckchem.com/products/2-nbdg.html
This review also reports about 90 clinical cases, thereby showing the biological interest of these modulators in multiple pathologies. Cytochrome P450 1B1 (CYP1B1) is a promising target for prevention and therapy of cancer, particularly those with drug resistance, stimulating cancer cell survival, and promoting cancer resistance. In view of the extreme complexity and high risk in drug discovery and development, a drug repurposing strategy was applied in the present study to find potential CYP1B1 inhibitors through structure-based virtual
Like
Comment
Share
